- Home
- CPT vs PEN Comparison
CPT vs PEN Comparison
Compare CPT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPT | PEN |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 12.8B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CPT | PEN |
|---|---|---|
| Price | $110.38 | $317.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 16 |
| Target Price | $115.28 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.2M | 368.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | 136.00 | ★ 1155.56 |
| EPS | 0.40 | ★ 0.82 |
| Revenue | $12,967,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | N/A | $14.34 |
| Revenue Next Year | $2.60 | $13.71 |
| P/E Ratio | ★ $271.68 | $385.61 |
| Revenue Growth | ★ 81.69 | 17.50 |
| 52 Week Low | $96.53 | $221.26 |
| 52 Week High | $116.59 | $362.41 |
Technical Indicators
Market Signals| Indicator | CPT | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.91 | 38.52 |
| Support Level | $105.56 | $302.19 |
| Resistance Level | $111.94 | $322.24 |
| Average True Range (ATR) | 2.50 | 2.37 |
| MACD | -0.61 | -0.04 |
| Stochastic Oscillator | 42.77 | 28.87 |
Price Performance
Historical ComparisonAbout CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.
About PEN Penumbra Inc.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.